| Literature DB >> 34072651 |
Hanieh Mohammadi1,2, Christine Gagnon1, Thomas Vincent1, Ali Kassab3, Sarah Fraser4, Anil Nigam1, Frédéric Lesage1,5, Louis Bherer1,2,6.
Abstract
Recent studies have shown that optical indices of cerebral pulsatility, including cerebral pulse amplitude, are linked to cerebrovascular health. A chronically higher cerebral pulsatility is associated with cognitive decline. Although it is widely known that regular physical activity improves cognitive functions, little is known about the association between physical activity and the optical index of cerebral pulsatility. This study assessed the impact of 12 months of regular physical activity on the changes in the optical index of cerebral pulsatility and explored its association with cognition. A total of 19 older adults (aged 59-79 years) with cardiovascular risk factors (CVRF) completed the study. Low-intensity, short-duration walking as a brief cardiovascular challenge was used to study the impact of regular physical activity on post-walking changes in cerebral pulsatility index. The participants walked on a gym track while a near-infrared spectroscopy (NIRS) device recorded hemodynamics data from the frontal and motor cortex subregions. Our data indicated that 12 months of physical activity was associated with lower global cerebral pulse amplitude, which was associated with higher cognitive scores in executive functions. Further, the global cerebral pulsatility index was reduced after short-duration walking, and this reduction was greater after 12 months of regular physical activity compared with the baseline. This may be an indication of improvement in cerebrovascular response to the cardiovascular challenge after regular physical activity. This study suggests that 12 months of physical activity may support cognitive functions through improving cerebral pulsatility in older adults with CVRF.Entities:
Keywords: cardiovascular risk factors; cerebral pulsatility; longitudinal; near-infrared spectroscopy; physical activity
Year: 2021 PMID: 34072651 PMCID: PMC8230110 DOI: 10.3390/brainsci11060730
Source DB: PubMed Journal: Brain Sci ISSN: 2076-3425
Summary of demographic characteristics of the participants.
| Characteristics | CVRF_T0 ( | CVRF_T12 ( |
|---|---|---|
| Female/male ( | 13/6 | 13/6 |
| Age (years) | 68.05 (4.99) | 69.05 (4.99) |
| Resting SBP (mmHg) | 124.57 (13.55) | 120.5 (12.09) |
| Resting DBP (mmHg) | 75.9 (5.68) | 75.88 (6.97) |
| Pulse pressure (mmHg) | 54.35 (11.33) | 50.61 (8.93) |
| BMI (kg/m2) | 26.99 (3.93) | 26.81 (3.59) |
| Smoking, | 4 (21.05) | 4 (21.05) |
| Walking distance (m) | 33.04 (3.90) | 33.23 (5.92) |
| Walking speed (m·s−1) | 1.10 (0.13) | 1.10 (0.19) |
|
| ||
| PASE score | 127.20 (68.51) | 124.90 (44.38) |
| Frequency of sessions per week | 1.94 (0.76) | 2.01 (0.87) |
| Duration of sessions (hour/week) | 3.45 (2.33) | 2.57 (1.52) |
| Intensity of physical activity * | 4.31 (2.11) | 4.07 (1.65) |
|
| ||
| Total-cholesterol (mmol·L−1) | 4.47 (1.14) | 4.91 (1.29) |
| LDL-cholesterol (mmol·L−1) | 2.92 (1.92) | 2.81 (0.65) |
| HDL-cholesterol (mmol·L−1) | 1.35 (0.54) | 1.64 (0.29) |
|
| ||
| Aspirin, | 1 (0.05) | 1 (0.05) |
| Beta-blockers, | 2 (10.53) | 1 (0.05) |
| Statin, | 4 (21.05) | 4 (21.05) |
| ACE-inhibitor, | 2 (11.54) | 3 (15.79) |
| ARA, | 3 (15.79) | 3 (15.79) |
Abbreviations are mean (standard deviation); n: number of participants; % percent of participants; SBP: systolic blood pressure; DBP: diastolic blood pressure; BMI: body mass index; PASE: physical activity scale for older adults; (*) intensity of physical activity is in Borg scale; LDL: low-density lipoprotein; HDL: high-density lipoprotein; ACE: angiotensin converting enzyme; ARA: angiotensin antagonist receptor.
Response time for four conditions of the Stroop test for the study population (n = 19).
| Stroop Condition | Response Time (T0) | Response Time (T12) | |
|---|---|---|---|
| Naming | 31.52 (7.41) | 29.105 (9.32) | |
| Reading | 22.05 (3.68) | 21.26 (6.41) | |
| Inhibition | 58.21 (20.57) | 54.05 (18.06) | |
| Switching | 63.05 (5.68) | 56.63 (18.35) |
Numbers shows four conditions of the Stroop test. Response times are reported in sec. The results reported as mean (standard deviation). The t-test shows the p-values for comparison of the response time between T0 and T12. The star sign or (**) shows the result of paired t-test results for comparison of the response time T0 versus T12, and (*) shows statistically significant difference between the values for p < 0.05.
Figure 1(A) Frontal view of the source and detector placements on the Colin27 template. Red dots represent the NIRS sources, and green dots represent detectors. The source and detector arrangement covered frontal and parietal cortex subregions. (B) Example of a single cerebral pulse waveform for a channel of a participant. The change in intensity between the systolic (red dot) and the diastolic (blue dots) peaks represents cerebral pulse amplitude (adapted from [24]). x-axis is time (s) and y-axis is NIRS signal intensity.
Figure 2The boxplots of global cerebral pulse amplitude (averaged across all the channels) for before walking at baseline (T0) and after 12 months (T12). BW, AW and SD are abbreviations for standing rest before walking, standing rest after walking and standard deviation respectively.
Figure 3(Left) Channel-wise spatial distribution of the cerebral pulse amplitude projected on the cortex Colin27 template at baseline (T0) and after 12 months of physical activity (T12). (Right) t-statistics topographic contrast maps for the channel-wise comparison of cerebral pulse amplitude. These maps are thresholded and are FDR-corrected (p < 0.05).